SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-003719
Filing Date
2018-05-09
Accepted
2018-05-09 14:10:57
Documents
49
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050918p.htm 10-Q 589616
2 EXHIBIT 10.1 exh_101.htm EX-10.1 2087
3 EXHIBIT 31.1 exh_311.htm EX-31.1 11240
4 EXHIBIT 31.2 exh_312.htm EX-31.2 11594
5 EXHIBIT 32.1 exh_321.htm EX-32.1 4300
6 EXHIBIT 32.2 exh_322.htm EX-32.2 4253
13 GRAPHIC exh101_1.jpg GRAPHIC 239747
14 GRAPHIC exh101_2.jpg GRAPHIC 211996
15 GRAPHIC exh101_3.jpg GRAPHIC 140970
  Complete submission text file 0001171843-18-003719.txt   4905287

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE bcrx-20180331.xml EX-101.INS 775202
8 XBRL SCHEMA FILE bcrx-20180331.xsd EX-101.SCH 48597
9 XBRL CALCULATION FILE bcrx-20180331_cal.xml EX-101.CAL 34667
10 XBRL DEFINITION FILE bcrx-20180331_def.xml EX-101.DEF 342692
11 XBRL LABEL FILE bcrx-20180331_lab.xml EX-101.LAB 327072
12 XBRL PRESENTATION FILE bcrx-20180331_pre.xml EX-101.PRE 349951
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 18817727
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1